Extracellular CIRP dysregulates macrophage bacterial phagocytosis in sepsis

Mian Zhou1, Monowar Aziz1,2, Hao-Ting Yen1

  • 1Center for Immunology and Inflammation, The Feinstein Institutes for Medical Research, Manhasset, NY, USA.

Insights

Extracellular cold-inducible RNA-binding protein (eCIRP) impairs macrophage bacterial phagocytosis during sepsis. Inhibiting eCIRP or its downstream signaling pathway improves bacterial clearance and survival.

Area of Science:

  • Immunology
  • Cellular Biology
  • Molecular Medicine

Background:

  • Sepsis is characterized by impaired macrophage bacterial phagocytosis, a critical immune defense mechanism.
  • The precise molecular mechanisms underlying this phagocytic dysfunction remain incompletely understood.
  • Extracellular cold-inducible RNA-binding protein (eCIRP), a damage-associated molecular pattern, is known to induce inflammation but its role in phagocytosis is unexplored.

Purpose of the Study:

  • To investigate the role of extracellular cold-inducible RNA-binding protein (eCIRP) in regulating macrophage bacterial phagocytosis during sepsis.
  • To elucidate the molecular pathways through which eCIRP affects phagocytic function.
  • To identify eCIRP as a potential therapeutic target for sepsis treatment.

Main Methods:

  • Utilized CIRP knockout (CIRP-/-) mice and anti-eCIRP antibody treatment in a sepsis model.
  • Assessed bacterial loads, survival rates, and macrophage phagocytic activity in vivo and in vitro.
  • Analyzed protein expression of key regulators of actin remodeling, including ARP2, p-cofilin, and βPIX, using Western blotting.
  • Investigated the interaction between STAT3 and βPIX and the role of STAT3 phosphorylation via immunoprecipitation and Western blotting.
  • Employed the STAT3 inhibitor stattic to assess its effect on macrophage phagocytosis.

Main Results:

  • CIRP-/- mice and anti-eCIRP antibody-treated mice exhibited reduced bacterial loads and improved survival post-sepsis.
  • Increased eCIRP levels correlated with decreased bacterial clearance in septic mice.
  • Recombinant murine CIRP (rmCIRP) significantly impaired macrophage phagocytosis both in vivo and in vitro.
  • rmCIRP treatment led to decreased expression of ARP2, p-cofilin, and βPIX, and inhibited Rac1 activation.
  • eCIRP-induced STAT3 phosphorylation formed a complex with βPIX, hindering Rac1 activation and actin remodeling.
  • Inhibition of STAT3 phosphorylation or targeting the STAT3-βPIX complex restored phagocytic function.

Conclusions:

  • Extracellular cold-inducible RNA-binding protein (eCIRP) directly impairs macrophage bacterial phagocytosis during sepsis.
  • The mechanism involves eCIRP-induced STAT3 phosphorylation, leading to the formation of a STAT3-βPIX complex that inhibits Rac1 activation and actin remodeling.
  • Targeting the eCIRP-STAT3 signaling pathway presents a promising therapeutic strategy to enhance macrophage function and improve outcomes in sepsis.